:i iiii ï {:] liii M1!11111[.1i

Similar documents
Volume 10 Cervix Cancer Screening

Cancer Incidence in Five Continents. Volume VIII

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

Previous volumes in this series

WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Volume 5. Sunscreens

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

NATIONAL COORDINATION MECHANISM FOR TOBACCO CONTROL A Model for the African Region

Diabetes. Halt the diabetes epidemic

NATIONAL AIDS PROGRAMME MANAGEMENT A SET OF TRAINING MODULES

GOOD PHARMACOPOEIAL PRACTICES

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

Photo Book: Identify Signs of Illness

Checklist for assessing the gender responsiveness of sexual and reproductive health policies. Pilot document for adaptation to national contexts

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

MONITORING HEALTH INEQUALITY

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

BEST PRACTICES FOR PLANNING A VACCINATION CAMPAIGN FOR AN ENTIRE POPULATION

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

State of InequalIty. Reproductive, maternal, newborn and child health. executi ve S ummary

Latent tuberculosis infection

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Overheads. Complementary Feeding Counselling a training course. World Health Organization

IMPLEMENTATION OF THE REVISED GENERAL

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network

CLINDAMYCIN PALMITATE

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

preventing suicide Regional strategy on

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

CANCER FACT SHEETS: STOMACH CANCER

Summary report on the WHO-EM/WRH/104/E

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Raising tobacco taxes in Bangladesh in FY : An opportunity for development

THE SELECTION AND USE OF ESSENTIAL MEDICINES

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

1.Nicotine - pharmacology 2.Nicotine - standards 3.Tobacco - chemistry 4.Smoking I.Title. ISBN (LC/NLM classification: HD 9130.

CANCER FACT SHEETS: BREAST CANCER

EMTRICITABINE AND TENOFOVIR TABLETS

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

Prelims-ESMO-Cancer Prevention-8039.qxd 12/12/2007 7:04 PM Page i. ESMO handbook of cancer prevention

CUTANEOUS LEISHMANIASIS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

WHO Emergency Risk Communication

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

CANCER FACT SHEETS: LIVER CANCER

CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER

Module 9 Strategic information

MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

Technical consultation on reducing sugar intake in the Eastern Mediterranean Region

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

Public Health Laboratories for Alert and Response. A WHO Guidance Document

Operational Guidance on Sharing Seasonal Influenza viruses with WHO Collaborating Centres (CCs) under the Global Influenza Surveillance and Response

Ouagadougou Declaration

A CINE ;MANUAL. oping co. The. roduction. ttf-yiéterinla vaccinë for use in "14. Agriculture. Organization 3 of. the. Nations. United. and. !

Cancer prevention and control in the context of an integrated approach

WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV) Situation update and overview of available guidance

Guidelines for scaling-up the 100% condom use programme:

FNA Cytology of Soft Tissue and Bone Tumors

20 Questions & Answers

Bulletin of the National Radiation and Epidemiological Registry ENGLISH TRANSLATION OF RUSSIAN SPESIAL ISSUE

Frozen Section Library Series Editor Philip T. Cagle, MD Houston, Texas, USA

CONTENTS NOTE TO THE READER... 1

Latent tuberculosis infection

Maurie Markman, MD, Series Editor

Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer

Summary report on the WHO-EM/CSR/124/E

ECG INTERPRETATION: FROM PATHOPHYSIOLOGY TO CLINICAL APPLICATION

WEB ANNEX I. REPORT ON COST-EFFECTIVENESS OF IMPLEMENTING AN INDETERMINATE RANGE FOR EARLY INFANT DIAGNOSIS OF HIV

Essentials in Cytopathology Series

Scientific Council Fifty-first Session 21/11/2014

Group Exercises for Addiction Counseling

2009 Report. Tuberculosis Control. in the Western Pacific Region

Handbook of Pediatric Eye and Systemic Disease

Trauma and Forgiveness

Cancer Treatment and Research

Dental Nurse Survival Guide

PRINCIPLES FOR EVALUATING HEALTH RISKS IN CHILDREN ASSOCIATED WITH EXPOSURE TO CHEMICALS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

Working in Secure Forensic Mental Health Settings

Annie J. Sasco, MD, MPH, MS, DrPH

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

The Pharmacology of Alcohol and Drugs of Abuse and Addiction

SPRINGER BRIEFS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. Gerhard Bauer Joseph S. Anderson. Gene Therapy for HIV From Inception to a Possible Cure

Transcription:

:i iiii ï {:] liii 1111 1M1!11111[.1i

International Agency For Research On Cancer The International Agency for Research on Cancer (]ARC) was established in 1965 by the World Health Assembly, as an independently financed organization within the framework of the World Health Organization. The headquarters of the Agency are in Lyon, France. The Agency conducts a programme of research concentrating particularly on the epidemiology of cancer and the study of potential carcinogens in the human environment. Its field studies are supplemented by biological and chemical research carried out in the Agency's laboratories in Lyon and, through collaborative research agreements, in national research institutions in many countries. The Agency also conducts a programme for the education and training of personnel for cancer research. The publications of the Agency contribute to the dissemination of authoritative information on different aspects of cancer research. A complete list is printed at the back of this book. Information about IARC publications, and how to order them, is also available via the Internet at: httpllwww.iarc.tr/ Cover illustrations Top left: Bottom left: Top right: Bottom right: Mammography Confocal laser microscopy of an eosinophilic granulocyte from the lung Tubular adenoma of the colon (N.J. Carr) COX-2 expression in human hepatocellular carcinoma (S. Sakisaka)

Mdl ~n* in Cancer Edited by A.B. Miller, H. Bartsch, P. Boffetta, L. Dragsted and H. Vainio IARC Scientific Publications No. 154 International Agency for Research on Cancer, Lyon, 2001

Published by the International Agency for Research on Cancer, 150 cours Albert Thomas, F-69372 Lyon cedex 08, France International Agency for Research on Cancer, 2001 Distributed by Oxford University Press, Walton Street, Oxford, UK 0X2 6DP (Fax: +44 1865 267782) and in the USA by Oxford University Press, 2001 Evans Road, Carey, NC 27513, USA (Fax: +1 919 677 1303). All LARC publications can also be ordered directly frein larcpress (Fax: +33 4 72 73 83 02; E-mail: press@iarc.fr). Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. AIE rights reserved. The designations used and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The authors alone are responsible for the views expressed in this publication. The International Agency for Research on Cancer welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Editorial & Publications Service, International Agency for Research on Cancer, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. IARC Library Cataloguing in Publication Data Biomarkers in Cancer Chemoprevention editors, A.B. Miller... [et a].j (FARC Scientific Publication; 154) 1. Biological Markers. 2. Neoplasms - prevention & control. I. Miller, A.B. (Anthony B). Il. Title III. Series ISBN 92 832 2154 0 ISSN 0300-5085 (NLM Classification: Wi) Achevé d'imprimer our rotative par l'imprimerie Darantiere à Dijon-Quetigny en décembre 2000 Dépôt légal décembre 2000 - N d'impression : 20-1352